Putting the Brakes on Huntington Disease in a Mouse Experimental Model.

Kim JC, Mirkin SM.

PLoS Genet. 2015 Aug 6;11(8):e1005409. doi: 10.1371/journal.pgen.1005409. No abstract available.

Balancing needs as a family caregiver in Huntington's disease: a qualitative interview study.

Røthing M, Malterud K, Frich JC.

Health Soc Care Community. 2015 Sep;23(5):569-76. doi: 10.1111/hsc.12174.

HTT/Huntingtin in selective autophagy and Huntington disease: A foe or a friend within?

Rui YN, Xu Z, Patel B, Cuervo AM, Zhang S.

Autophagy. 2015;11(5):858-60. doi: 10.1080/15548627.2015.1039219. No abstract available.

Deep brain stimulation in Huntington's disease: assessment of potential targets.

Sharma M, Deogaonkar M.

J Clin Neurosci. 2015 May;22(5):812-7. doi: 10.1016/j.jocn.2014.11.008. Review.

Transcriptional dysregulation in Huntington's disease: The role of histone deacetylases.

Sharma S, Taliyan R.

Pharmacol Res. 2015 Oct;100:157-69. doi: 10.1016/j.phrs.2015.08.002. Review.

Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Bai G, Cheung I, Shulha HP, Coelho JE, Li P, Dong X, Jakovcevski M, Wang Y, Grigorenko A, Jiang Y, Hoss A, Patel K, Zheng M, Rogaev E, Myers RH, Weng Z, Akbarian S, Chen JF.

Hum Mol Genet. 2015 Mar 1;24(5):1441-56. doi: 10.1093/hmg/ddu561.

High Protein Diet and Huntington's Disease.

Chen CM, Lin YS, Wu YR, Chen P, Tsai FJ, Yang CL, Tsao YT, Chang W, Hsieh IS, Chern Y, Soong BW.

PLoS One. 2015 May 19;10(5):e0127654. doi: 10.1371/journal.pone.0127654.

Neonatal iron supplementation potentiates oxidative stress, energetic dysfunction and neurodegeneration in the R6/2 mouse model of Huntington's disease.

Berggren KL, Chen J, Fox J, Miller J, Dodds L, Dugas B, Vargas L, Lothian A, McAllum E, Volitakis I, Roberts B, Bush AI, Fox JH.

Redox Biol. 2015;4:363-74. doi: 10.1016/j.redox.2015.02.002.

Language Impairment in Adolescents With Sydenham Chorea.

Harsányi E, Moreira J, Kummer A, Meira ZM, Cardoso F, Teixeira AL.

Pediatr Neurol. 2015 Nov;53(5):412-6. doi: 10.1016/j.pediatrneurol.2015.06.022.

Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden.

Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS; PREDICT-HD Investigators of the Huntington Study Group..

J Int Neuropsychol Soc. 2015 Jan;21(1):8-21. doi: 10.1017/S1355617714001076.

Depletion of p62 reduces nuclear inclusions and paradoxically ameliorates disease phenotypes in Huntington's model mice.

Kurosawa M, Matsumoto G, Kino Y, Okuno M, Kurosawa-Yamada M, Washizu C, Taniguchi H, Nakaso K, Yanagawa T, Warabi E, Shimogori T, Sakurai T, Hattori N, Nukina N.

Hum Mol Genet. 2015 Feb 15;24(4):1092-105. doi: 10.1093/hmg/ddu522.

Counterfactual Thinking Deficit in Huntington's Disease.

Solca F, Poletti B, Zago S, Crespi C, Sassone F, Lafronza A, Maraschi AM, Sassone J, Silani V, Ciammola A.

PLoS One. 2015 Jun 12;10(6):e0126773. doi: 10.1371/journal.pone.0126773.

Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice.

Achour M, Le Gras S, Keime C, Parmentier F, Lejeune FX, Boutillier AL, Néri C, Davidson I, Merienne K.

Hum Mol Genet. 2015 Jun 15;24(12):3481-96. doi: 10.1093/hmg/ddv099.

Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.

Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Muñoz E, Sagredo O.

Neurotherapeutics. 2015 Jan;12(1):185-99. doi: 10.1007/s13311-014-0304-z.

Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

Krause A, Mitchell C, Essop F, Tager S, Temlett J, Stevanin G, Ross C, Rudnicki D, Margolis R.

Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):573-85. doi: 10.1002/ajmg.b.32332.